%0 Historical Article
%T A journey through the history of PEGylated drug delivery nanocarriers.
%A López-Estevez AM
%A Gref R
%A Alonso MJ
%J Drug Deliv Transl Res
%V 14
%N 8
%D 2024 Aug 25
%M 38796665
%F 5.671
%R 10.1007/s13346-024-01608-8
%X This note aims to inspire through providing a personal view of the development and potential Drug Delivery Nanocarriers functionalized with polythyleneglycol (PEG). This polymer has been used extensively in Pharmaceutical Technology in a variety of compositions, including polyethylene oxide (PEO)-based surfactants. However, the concept of PEGylation, which started in the 70's, differs from the functionality of a surfactant, already discloses in the 50's. Here, we strictly adhere to the biological functionality of PEGylated nanocarriers intended to have a reduced interaction with proteins and, therefore, modify their biodistribution as well as facilitate their diffusion across mucus and other biological barriers. We analyze how this concept has evolved over the years and the benefit obtained so far in terms of marketed nanomedicines and provide the readers with a prospect view of the topic.